Journal: iScience
Article Title: HHEX-PRKAR2B axis-mediated PKA activation drives glucose metabolism-dependent progression of pancreatic ductal adenocarcinoma
doi: 10.1016/j.isci.2026.114691
Figure Lengend Snippet: In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of Ki67 IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
Article Snippet: Primary antibody against Ki67 (1:500 dilution, cat. 12202, Cell Signaling Technology, MA, USA) was prepared in SignalStain Antibody Diluent (cat. 8112, Cell Signaling Technology) and applied to the sections overnight at 4°C.
Techniques: In Vivo, Western Blot, Knock-Out, Cell Culture, Staining, Expressing, Injection, Activity Assay, Immunohistochemistry, Control